勒梅特微管医疗 LMAT 深 沪
等待开盘 10-02 09:30:00 美东时间
86.67
-0.840
-0.96%
华盛通- 最 高88.245
- 今 开86.83
- 成交量 14.72万股
- 最 低 84.4115
- 昨 收 87.51
- 总市值 19.62亿
- 52周最高 108.98
- 市盈率 静 44.83
- 换手率 0.65%
- 52周最低 71.02
- 委 比 83.19%
- 总股本 2263.75万
- 历史最高 108.98
- 量 比 0.73
- 振 幅 4.38%
- 历史最低 0.395
- 每 手 1
- 风险率 7.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $95 price target.
09-23 23:15
LeMaitre to Participate at Upcoming Investor Conferences in September
LeMaitre Vascular Inc. announced that CFO Dorian LeBlanc will participate in four upcoming investor conferences: the 2025 Wells Fargo Healthcare Conference on September 3 at Encore Boston Harbor, the Cantor Global Healthcare Conference on September 4 in New York, the Morgan Stanley Global Healthcare Conference on September 9 in New York, and the Barrington Research Fall Investment Conference on September 16. The company, a provider of devices and...
08-28 20:35
Barrington Research Upgrades LeMaitre Vascular to Outperform, Announces $95 Price Target
Barrington Research analyst Michael Petusky upgrades LeMaitre Vascular (NASDAQ:LMAT) from Market Perform to Outperform and announces $95 price target.
08-06 21:06
LeMaitre Vascular Sees Q3 GAAP EPS $0.54-$0.59 vs $0.54 Est; Sees Sales $61.200M-$63.200M vs $60.923M Est
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q3 GAAP EPS of $0.54-$0.59 vs $0.54 analyst estimate. sees sales of $61.200 million-$63.200 million vs $60.923 million analyst estimate.
08-06 04:23
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Barrington Research Reiterates Market Perform on LeMaitre Vascularto Market Perform
Barrington Research analyst Michael Petusky reiterates LeMaitre Vascular (NASDAQ:LMAT) from Market Perform to Market Perform.
07-22 22:27
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025
LeMaitre Vascular, Inc. announced the release of its second quarter 2025 financial results on August 5, 2025, after market close, followed by a conference call at 5:00 PM EDT to discuss the results, business highlights, and company outlook. Interested parties can register online for the call and access the audio webcast at ir.lemaitre.com. LeMaitre is a leading provider of devices and services for treating peripheral vascular disease.
07-08 20:04
Elutia Inc. Ends Distribution Agreement with LeMaitre
An update from Aziyo Biologics ( ($ELUT) ) is now available. On April 30, 2025,...
05-07 05:15
Earnings Scheduled For May 1, 2025
Companies Reporting Before The Bell • Itron (NASDAQ:ITRI) is projected to repor...
05-01 16:32
